Magdalena Kowalczyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Magdalena Kowalczyk has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kacper Kraśnik
Student Scientific Society of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, ul. Jaczewskiego 4, 20-090 Lublin, Poland
2 shared publications - Dawid Grela
Medical University of Lublin: Lublin, Poland
1 shared publication - Filip Kuca
Students’ Scientific Association at the Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland
1 shared publication - Kacper Curzytek
University Clinical Hospital No. 1 in Lublin, Poland
1 shared publication - Maciej Kolasa
Students’ Scientific Association at the Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, Lublin, Poland
1 shared publication - Maria Szafranek
Medical University of Lublin: Lublin, Poland
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
MICRO- AND NANOPLASTICS IN INFLAMMATORY BOWEL DISEASE: FROM EXPERIMENTAL MODELS TO HUMAN EVIDENCE
Research objectives: Micro- and nanoplastics (MNPs) are pervasive environmental contaminants that may affect gastrointestinal health. This narrative review aimed to evaluate current mechanistic, experimental, and human evidence concerning the potential relationship between MNP exposure and inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. Methods: PubMed, Scopus, and Google Scholar were searched for human, animal, and in vitro studies investigating MNP exposure in IBD, experimental colitis, ileitis, intestinal inflammation, or mechanisms relevant to IBD pathogenesis. Studies addressing epithelial barrier dysfunction, mucus alterations, oxidative stress, immune activation, dysbiosis, and epithelial cell death were included. The evidence was synthesized descriptively because of substantial methodological heterogeneity. Key findings: Experimental studies indicate that MNPs can impair the intestinal mucus layer and epithelial junctions, increase permeability, promote oxidative and mitochondrial stress, activate inflammatory pathways, alter the gut microbiota and microbial metabolites, and disturb epithelial regeneration. In healthy animals, these effects were generally mild, subclinical, or inconsistent, and MNP exposure alone did not reliably produce an IBD-like phenotype. In contrast, most chemically induced colitis models showed greater mucosal injury, inflammation, permeability, delayed healing, fibrosis, or colitis-associated tumorigenesis after MNP exposure. Human studies reported higher fecal microplastic concentrations in IBD and associations with disease activity and Crohn’s disease-related fibrosis, but evidence remains limited. Conclusions: MNPs should currently be regarded as potential environmental modifiers of IBD rather than established etiological agents. Prospective studies using standardized exposure assessment and separate analyses of ulcerative colitis and Crohn’s disease are required to clarify causal relationships.
- 28 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessMICRO- AND NANOPLASTICS IN INFLAMMATORY BOWEL DISEASE: FROM EXPERIMENTAL MODELS TO HUMAN EVIDENCE
Research objectives: Micro- and nanoplastics (MNPs) are pervasive environmental contaminants that may affect gastrointestinal health. This narrative review aimed to evaluate current mechanistic, experimental, and human evidence concerning the potential relationship between MNP exposure and inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. Methods: PubMed, Scopus, and Google Scholar were searched for human, animal, and in vitro studies investigating MNP exposure in IBD, experimental colitis, ileitis, intestinal inflammation, or mechanisms relevant to IBD pathogenesis. Studies addressing epithelial barrier dysfunction, mucus alterations, oxidative stress, immune activation, dysbiosis, and epithelial cell death were included. The evidence was synthesized descriptively because of substantial methodological heterogeneity. Key findings: Experimental studies indicate that MNPs can impair the intestinal mucus layer and epithelial junctions, increase permeability, promote oxidative and mitochondrial stress, activate inflammatory pathways, alter the gut microbiota and microbial metabolites, and disturb epithelial regeneration. In healthy animals, these effects were generally mild, subclinical, or inconsistent, and MNP exposure alone did not reliably produce an IBD-like phenotype. In contrast, most chemically induced colitis models showed greater mucosal injury, inflammation, permeability, delayed healing, fibrosis, or colitis-associated tumorigenesis after MNP exposure. Human studies reported higher fecal microplastic concentrations in IBD and associations with disease activity and Crohn’s disease-related fibrosis, but evidence remains limited. Conclusions: MNPs should currently be regarded as potential environmental modifiers of IBD rather than established etiological agents. Prospective studies using standardized exposure assessment and separate analyses of ulcerative colitis and Crohn’s disease are required to clarify causal relationships.
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
CLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION IN CHILDREN
Left ventricular noncompaction (LVNC) is a heterogeneous form of cardiomyopathy associated with abnormal myocardial maturation and characteristic prominent trabeculation of the left ventricular wall. The classification of the disease remains controversial, and some authors consider LVNC to represent a phenotypic manifestation of other cardiomyopathies. The clinical presentation, particularly in children, is highly variable, ranging from asymptomatic forms to heart failure, arrhythmias, and thromboembolic events. Echocardiography remains the cornerstone of diagnosis, complemented by cardiac magnetic resonance imaging; however, the lack of universally accepted diagnostic criteria contributes to the risk of overdiagnosis. Treatment is primarily symptomatic and depends on the disease phenotype and the degree of left ventricular dysfunction. Prognosis is determined mainly by cardiac function and the presence of arrhythmias, whereas isolated LVNC with preserved systolic function is generally associated with a favorable clinical course.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessCLINICAL PRESENTATION OF LEFT VENTRICULAR NONCOMPACTION IN CHILDREN
Left ventricular noncompaction (LVNC) is a heterogeneous form of cardiomyopathy associated with abnormal myocardial maturation and characteristic prominent trabeculation of the left ventricular wall. The classification of the disease remains controversial, and some authors consider LVNC to represent a phenotypic manifestation of other cardiomyopathies. The clinical presentation, particularly in children, is highly variable, ranging from asymptomatic forms to heart failure, arrhythmias, and thromboembolic events. Echocardiography remains the cornerstone of diagnosis, complemented by cardiac magnetic resonance imaging; however, the lack of universally accepted diagnostic criteria contributes to the risk of overdiagnosis. Treatment is primarily symptomatic and depends on the disease phenotype and the degree of left ventricular dysfunction. Prognosis is determined mainly by cardiac function and the presence of arrhythmias, whereas isolated LVNC with preserved systolic function is generally associated with a favorable clinical course.